Reversible cerebellar toxicity during treatment with ornidazole: the first case report.
Taskapilioglu
O
O
Seferoglu
M
M
Kaygili
E
E
Hakyemez
B
B
Zarifoglu
M
M
D000563:Amebicides / Q000627:therapeutic use / Q000633:toxicity*; D002524:Cerebellar Ataxia / Q000139:chemically induced / Q000175:diagnosis; D002526:Cerebellar Diseases / Q000139:chemically induced* / Q000175:diagnosis; D002529:Cerebellar Nuclei / Q000187:drug effects / Q000473:pathology; D003337:Corpus Callosum / Q000187:drug effects / Q000473:pathology; D038524:Diffusion Magnetic Resonance Imaging; D004359:Drug Therapy, Combination; D004401:Dysarthria / Q000139:chemically induced / Q000175:diagnosis; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009950:Ornidazole / Q000627:therapeutic use / Q000633:toxicity*; D010437:Peptic Ulcer / Q000188:drug therapy*; D011149:Pons / Q000187:drug effects / Q000473:pathology; D013681:Tegmentum Mesencephali / Q000187:drug effects / Q000473:pathology; D055815:Young Adult
D000563:Amebicides; D009950:Ornidazole